InvestorsObserver
×
News Home

Is Zogenix, Inc. (ZGNX) the Top Pick in the Biotechnology Industry?

Friday, December 18, 2020 11:04 AM | InvestorsObserver Analysts

Mentioned in this article

Is Zogenix, Inc. (ZGNX) the Top Pick in the Biotechnology Industry?

Zogenix, Inc. (ZGNX) is near the bottom in its industry group according to InvestorsObserver. ZGNX gets an overall rating of 35. That means it scores higher than 35 percent of stocks. Zogenix, Inc. gets a 27 rank in the Biotechnology industry. Biotechnology is number 28 out of 148 industries.

Overall Score - 35
ZGNX has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on ZGNX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 35 would rank higher than 35 percent of all stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Zogenix, Inc. Stock Today?

Zogenix, Inc. (ZGNX) stock is trading at $20.22 as of 11:01 AM on Friday, Dec 18, a loss of -$0.08, or -0.39% from the previous closing price of $20.30. The stock has traded between $19.87 and $20.41 so far today. Volume today is less active than usual. So far 308,229 shares have traded compared to average volume of 863,394 shares.

Click Here to get the full Stock Score Report on Zogenix, Inc. (ZGNX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App